藥明生物
WuXi Biologics (Cayman) IncUSUSDWuXi Biologics (Cayman) Inc (US:WXIBF) — Biotechnology. Número de bolsas en las que cotizan las acciones de la empresa: 2. En esta página: cotización y gráfico, dividendos, principales accionistas e historial del número de acciones.
Sobre la empresa
- Sitio web
- wuxibiologics.com
- Sector
- Healthcare · Biotechnology
- Sede central
- Wuxi, China
- Consejero delegado
- Dr. Zhisheng Chen Ph.D.
- Empleados
- 14 705
- Acciones en circulación
- Capital flotante
- 3.71 mil M
- Capitalización bursátil
- 222.72 mil M HKD
- Insiders
- 10.12%
- Inversores institucionales
- 36.36%
- Forma jurídica
- OSBR
- ISIN
- KYG970081173
- LEI
- 5493001TD2TH6VDTJU11
Descripción
WuXi Biologics (Cayman) Inc., an investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People's Republic of China, North America, Europe, Singapore, Japan, South Korea, Australia, and Brazil. It operates through two segments: Biologics and XDC. The company provides a suite of solutions for biologic discovery, from concept to IND, that seamlessly transits to CMC and downstream process development through its contract research, development, and manufacturing organization platforms, including WuXiBody, SDArBodY, T cell engager, Tumor Associated Antigens (TAA) mAb Technology, Single B Cell Cloning Technology, WuXia, WuXiUP, WuXiUI, and WuXiHigh. It engages in the provision of consultation services in relation to the biopharmaceutical technology, international sales contracting services, testing and development of testing technologies, sales and marketing services, production and sales of medicals, and biologics clinical and manufacturing services; research and development in relation to biologics; international sales contracting service; vaccine contract development and manufacturing organization (CDMO) and related business; development, production, and distribution of biotechnological products; and engages in investment and material supplier activities. WuXi Biologics (Cayman) Inc. was incorporated in 2014 and is headquartered in Wuxi, China.
Dividendos
No se han encontrado pagos de dividendos (comprobado el 09.10.2026). Es probable que la empresa no reparta dividendos.
Noticias de esta semana
Comunicados de prensa desde la página web para inversores de la empresa, actualizados diariamente. Los enlaces conducen a la página web de la empresa. Los titulares están en el idioma original, como en la página web de la empresa.
Principales accionistas
| Titular | Participación | Acciones | Fecha del informe |
|---|---|---|---|
| VANGUARD STAR FUNDS-Vang… | 1.34% | 55.13 M | 2026-07-31 |
| VANGUARD Intl Eqy. INDEX… | 1.27% | 52.41 M | 2026-07-31 |
| Chen (Zhisheng) (Chief E… | ≈1.19% | 49.19 M | 2026-09-11 |
| iShares, Inc.-iShares Co… | 0.97% | 40.12 M | 2026-08-31 |
| VANGUARD WORLD FUND-Vang… | 0.92% | 37.93 M | 2026-05-31 |
| American Century ETF Tru… | 0.27% | 11.01 M | 2026-08-31 |
| J.P. Morgan Exch-Trd Fd.… | 0.26% | 10.87 M | 2026-07-31 |
| VANGUARD Intl Eqy. INDEX… | 0.22% | 8.96 M | 2026-07-31 |
| iShares, Inc.-iShares MS… | 0.22% | 8.91 M | 2026-08-31 |
| Baird Funds Inc-Baird Ch… | 0.21% | 8.77 M | 2026-07-31 |
| iShares Trust-iShares MS… | 0.21% | 8.76 M | 2026-08-31 |
| Zhou (Weichang) (Chief T… | ≈0.14% | 5.6 M | 2025-06-02 |
| Gu (Xuejun Sherry) (Chie… | ≈0.03% | 1.37 M | 2026-08-24 |
| Boston Common Asset Mana… | 0.02% | 869 000 | 2024-03-31 |
| Li (Ge) (Chairman of the… | — | — | 2026-01-20 |
